H.R. 3443 · 116th Congress

To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.

Stage
In committee
Sponsor
Diana DeGette
Introduced
2019-06-24
Latest action
2019-07-24 · Sponsor introductory remarks on measure.

Action history

  1. 2019-07-24Sponsor introductory remarks on measure.
  2. 2019-06-25Referred to the Subcommittee on Health.
  3. 2019-06-24Introduced in House
  4. 2019-06-24Referred to the House Committee on Energy and Commerce.